Other scientist group performed RNA expression profiling in AML patients possessing high/low TET1 expression and revealed that high TET1 expression predicts poor survival in two tested cytogenetically normal AML cohorts and is associated with a short survival time [41]. The gene discussed is TET1; the disease is acute myeloid leukemia.